Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01263587 · ClinicalTrials.gov registry record
Hepatitis B Research Network Adult Cohort Study
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 2,051
- Enrollment target
NCT01263587: Completed study, sponsored by University of Pittsburgh.
NCT01263587 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 2,051 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01263587 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 2,051 participants
- Enrollment target
Study Summary
The primary purpose of this study is to describe participants with hepatitis B virus (HBV) infection and identify factors that may cause the disease to activate or worsen.
Primary Outcome
A flare is defined as serum ALT greater than or equal to 10 times the upper limit of normal which corresponds to 300 IU/L in males or 200 IU/L in females. This definition will also be applied to hepatitis B surface antigen (HBsAg) positive pregnant women whose ALT levels increase during pregnancy or postpartum. Once a flare is detected, participants will be followed more closely until its resolution.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,051 participants |
| Start Date | 2010-12 |
| Est. Completion | 2021-06-09 |
What the finished NCT01263587 record still lists
NCT01263587 is an observational study that tracks outcomes without assigning an intervention. Its 2,051 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01263587 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01263587 about?
NCT01263587 is a clinical study titled "Hepatitis B Research Network Adult Cohort Study". The primary purpose of this study is to describe participants with hepatitis B virus (HBV) infection and identify factors that may cause the disease to activate or worsen.
What is the current status of trial NCT01263587?
This trial is currently completed. The enrollment target is 2,051 participants. The study started on 2010-12. Estimated completion is 2021-06-09.
Who is sponsoring clinical trial NCT01263587?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05050084 · 2,050 participants · Phase 3
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial
- NCT05688982 · 2,049 participants · NA
MOLAR: Mapping Oral Health and Local Area Resources
- NCT06833476 · 2,044 participants
TTVR STRONG Under Coverage With Evidence Development (CED) Study
- NCT05138718 · 2,041 participants
FDG an Myocardial Infarction: The PIAF Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia